Cardiff Oncology, Inc. (NASDAQ:CRDF) Q3 2023 Earnings Call Transcript November 2, 2023
Cardiff Oncology, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.29.
Operator: Welcome to the Cardiff Oncology third-quarter 2023 financial results and corporate update conference call. [Operator Instructions]. As a reminder, this call is being recorded today, November 2, 2023. I would now like to turn the conference call over to Kiki Patel of Gilmartin Group. Please go...